Lushang Health Industry Development Co.,Ltd. (SHSE:600223) said it plans to sell assets and liabilities related to real estate business to company's controlling shareholder or affiliates.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.68 CNY | +2.84% | -0.69% | -9.87% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.87% | 1.22B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 600223 Stock
- News Lushang Freda Pharmaceutical Co.,Ltd.
- Lushang Health Plans to Sell Real Estate Assets to Controlling Shareholder or Affiliates